Us Drugmaker
- All
- News
- Videos
-
Audi, Cheerios Maker General Mills Pause Advertising on Twitter After Elon Musk Takeover
Luxury carmaker Audi and General Mills, the maker of Cheerios, said on Thursday that they had paused advertising on the microblogging platform, nearly a week after Elon Musk's takeover was completed. Meanwhile, the Wall Street Journal reported on Thursday that Oreo maker Mondelez International and US drugmaker Pfizer also temporarily halted adverti...
-
Anti-Covid Pill "Active" Against Omicron: Merck
Merck's anti-Covid pill remains "active" against the Omicron variant, the US drugmaker said Friday, citing results from six laboratory studies.
-
Denmark First In European Union To Authorise Merck Covid Pill
Denmark on Thursday recommended US drugmaker Merck's anti-Covid treatment molnupiravir for at-risk patients with symptoms, becoming the first EU country to do so.
-
Pfizer Says "Already Working" On Vaccine Targeting 'Omicron' Variant
Pfizer has already started working on a version of its Covid-19 vaccine specifically targeting the 'Omicron' variant in case the current inoculation is not effective against the new strain, the US drugmaker's CEO Albert Bourla said Monday.
-
US Court Overturns Historic Opioid Ruling Against Drugmaker Johnson & Johnson
The Oklahoma State Supreme Court on Tuesday overturned a historic decision to fine US pharmaceutical giant Johnson & Johnson $465 million for its role in the opioid crisis.
-
Pfizer Requests US Emergency Authorisation For Covid Booster For Adults
Drugmakers Pfizer and BioNTech announced Tuesday they have formally submitted a request asking US officials for emergency authorization of their Covid-19 booster vaccine for people aged 18 and older.
-
Pfizer Seeks US Authorization Of Covid Vaccine For Ages 5-11
US drugmaker Pfizer said Thursday it has formally requested emergency use authorization for its Covid-19 vaccine in children age five to 11.
-
Serum Institute Allowed To Enrol 7-11 Year-Olds In Covid Vaccine Trial
The country's drug regulator today allowed vaccine maker Serum Institute to enrol kids aged 7-11 years for its trial of US drugmaker Novavax's COVID-19 vaccine.
-
AstraZeneca's Antibody Cocktail Fails to Prevent Covid: Study
AstraZeneca Plc's antibody cocktail was only 33% effective at preventing COVID-19 symptoms in people who had been exposed to the virus, failing a study that was key to the drugmaker's pandemic push.
-
Pfizer To Send 50 Million Covid Jabs To India, But With Riders: Report
US pharmaceutical giant Pfizer is likely to supply 50 million COVID-19 vaccines to India in 2021, albeit with a few conditions, sources told ANI on Wednesday. The drugmaker has asked for relaxations in some clauses, sources informed.
-
India, Pfizer Seek To Bridge Dispute Over Vaccine Indemnity: Report
Pfizer and the Indian government are seeking to resolve tensions over a demand by the US drugmaker for legal protection from any claims linked to the use of its COVID-19 vaccine in one of the world's biggest markets, two sources told Reuters.
-
India, Pfizer At Impasse Over Vaccine Indemnity Demand: Report
Pfizer and New Delhi are at loggerheads over a demand by the US drugmaker for legal protection from any claims linked to the use of its COVID-19 vaccine in one of the world's biggest markets, two sources told Reuters.
-
3 Indian Firms To Make, Sell US's Eli Lilly's Baricitinib Drug For Covid Treatment
Eli Lilly and Co said on Monday it had signed licensing agreements with three Indian generic drugmakers to expand the availability of its arthritis drug baricitinib in the country for treating COVID-19 patients.
-
Cipla To Make, Sell US's Eli Lilly's Baricitinib Drug For Covid Treatment
Indian drugmaker Cipla Ltd said on Monday it has entered into a licensing agreement with U.S. company Eli Lilly and Co to make and sell Lilly's arthritis drug baricitinib for the treatment of COVID-19 patients.
-
US Drugmaker To Donate 400,000 Covid Treatment Tablets To India
Eli Lilly and Co said on Tuesday it would supply 400,000 tablets of its COVID-19 treatment, to be used with Gilead's remdesivir, to India as the country fights a raging pandemic that has morgues and hospitals overflowing.
-
Audi, Cheerios Maker General Mills Pause Advertising on Twitter After Elon Musk Takeover
Luxury carmaker Audi and General Mills, the maker of Cheerios, said on Thursday that they had paused advertising on the microblogging platform, nearly a week after Elon Musk's takeover was completed. Meanwhile, the Wall Street Journal reported on Thursday that Oreo maker Mondelez International and US drugmaker Pfizer also temporarily halted adverti...
-
Anti-Covid Pill "Active" Against Omicron: Merck
Merck's anti-Covid pill remains "active" against the Omicron variant, the US drugmaker said Friday, citing results from six laboratory studies.
-
Denmark First In European Union To Authorise Merck Covid Pill
Denmark on Thursday recommended US drugmaker Merck's anti-Covid treatment molnupiravir for at-risk patients with symptoms, becoming the first EU country to do so.
-
Pfizer Says "Already Working" On Vaccine Targeting 'Omicron' Variant
Pfizer has already started working on a version of its Covid-19 vaccine specifically targeting the 'Omicron' variant in case the current inoculation is not effective against the new strain, the US drugmaker's CEO Albert Bourla said Monday.
-
US Court Overturns Historic Opioid Ruling Against Drugmaker Johnson & Johnson
The Oklahoma State Supreme Court on Tuesday overturned a historic decision to fine US pharmaceutical giant Johnson & Johnson $465 million for its role in the opioid crisis.
-
Pfizer Requests US Emergency Authorisation For Covid Booster For Adults
Drugmakers Pfizer and BioNTech announced Tuesday they have formally submitted a request asking US officials for emergency authorization of their Covid-19 booster vaccine for people aged 18 and older.
-
Pfizer Seeks US Authorization Of Covid Vaccine For Ages 5-11
US drugmaker Pfizer said Thursday it has formally requested emergency use authorization for its Covid-19 vaccine in children age five to 11.
-
Serum Institute Allowed To Enrol 7-11 Year-Olds In Covid Vaccine Trial
The country's drug regulator today allowed vaccine maker Serum Institute to enrol kids aged 7-11 years for its trial of US drugmaker Novavax's COVID-19 vaccine.
-
AstraZeneca's Antibody Cocktail Fails to Prevent Covid: Study
AstraZeneca Plc's antibody cocktail was only 33% effective at preventing COVID-19 symptoms in people who had been exposed to the virus, failing a study that was key to the drugmaker's pandemic push.
-
Pfizer To Send 50 Million Covid Jabs To India, But With Riders: Report
US pharmaceutical giant Pfizer is likely to supply 50 million COVID-19 vaccines to India in 2021, albeit with a few conditions, sources told ANI on Wednesday. The drugmaker has asked for relaxations in some clauses, sources informed.
-
India, Pfizer Seek To Bridge Dispute Over Vaccine Indemnity: Report
Pfizer and the Indian government are seeking to resolve tensions over a demand by the US drugmaker for legal protection from any claims linked to the use of its COVID-19 vaccine in one of the world's biggest markets, two sources told Reuters.
-
India, Pfizer At Impasse Over Vaccine Indemnity Demand: Report
Pfizer and New Delhi are at loggerheads over a demand by the US drugmaker for legal protection from any claims linked to the use of its COVID-19 vaccine in one of the world's biggest markets, two sources told Reuters.
-
3 Indian Firms To Make, Sell US's Eli Lilly's Baricitinib Drug For Covid Treatment
Eli Lilly and Co said on Monday it had signed licensing agreements with three Indian generic drugmakers to expand the availability of its arthritis drug baricitinib in the country for treating COVID-19 patients.
-
Cipla To Make, Sell US's Eli Lilly's Baricitinib Drug For Covid Treatment
Indian drugmaker Cipla Ltd said on Monday it has entered into a licensing agreement with U.S. company Eli Lilly and Co to make and sell Lilly's arthritis drug baricitinib for the treatment of COVID-19 patients.
-
US Drugmaker To Donate 400,000 Covid Treatment Tablets To India
Eli Lilly and Co said on Tuesday it would supply 400,000 tablets of its COVID-19 treatment, to be used with Gilead's remdesivir, to India as the country fights a raging pandemic that has morgues and hospitals overflowing.
